Cornerstone Capital Management Holdings’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$562K	Buy	40,375 +700	+2%	+$9.46K	﹤0.01%	995
2017 Q3	$733K	Buy	39,675 +1,600	+4%	+$26.7K	0.01%	988
2017 Q2	$642K	Sell	38,075 -723	-2%	-$11K	0.01%	996
2017 Q1	$517K	Buy	+38,798	New	+$608K	﹤0.01%	1053
2016 Q4	–	Sell	-11,600	Closed	-$135K	–	1454
2016 Q3	$135K	Buy	+11,600	New	+$136K	﹤0.01%	1232
2016 Q2	–	Sell	-707	Closed	-$7K	–	1538
2016 Q1	$7K	Sell	707 -29,425	-98%	-$317K	﹤0.01%	1473
2015 Q4	$447K	Sell	30,132 -10,968	-27%	-$184K	﹤0.01%	1055
2015 Q3	$675K	Sell	41,100 -2,200	-5%	-$45K	0.01%	948
2015 Q2	$987K	Buy	+43,300	New	+$862K	0.01%	870
2014 Q4	–	Sell	-16,099	Closed	-$183K	–	1344
2014 Q3	$183K	Sell	16,099 -51,001	-76%	-$582K	﹤0.01%	1113
2014 Q2	$810K	Buy	67,100 +23,150	+53%	+$273K	0.01%	907
2014 Q1	$512K	Buy	+43,950	New	+$744K	0.01%	980

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Cornerstone Capital Management Holdings's MNTA Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its Momenta Pharmaceuticals, Inc. (MNTA) stake by 1.8% in Q4 2017, buying an estimated $9.46K and bringing the position to 40,375 shares worth $562K. The position accounts for ﹤0.01% of the portfolio, ranked #995.

Cornerstone Capital Management Holdings first reported a position in MNTA in Q1 2014 and has held it in 12 quarters since. The position peaked at $987K in Q2 2015. 166 funds tracked by Wall St. Rank hold MNTA as of Q4 2017.

Cornerstone Capital Management Holdings held 40,375 shares of Momenta Pharmaceuticals, Inc. worth $562K as of Q4 2017.
Cornerstone Capital Management Holdings bought 700 Momenta Pharmaceuticals, Inc. shares in Q4 2017, an estimated $9.46K.
Momenta Pharmaceuticals, Inc. made up ﹤0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #995 holding.
Cornerstone Capital Management Holdings first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2014 and has held it in 12 quarters since.
Cornerstone Capital Management Holdings's Momenta Pharmaceuticals, Inc. position peaked at $987K in Q2 2015.
166 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.